NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/12/2025
Voltar para busca
Dado oficial do USPTO
UCB THE EPILEPSY COMPANY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
60
Atualização mais recente
19/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
16, 41, 42
Data de depósito
12/11/2007
Data de registro
06/01/2009
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/07/2019
Última transação
19/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
707
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
87
Localização do titular
B-1070 Bruxelles, BE
Examinador
SPILS,CAROL A
Unidade examinadora
L40
Descrição da marca
The mark consists of. wording "THE" and "COMPANY" as well as in the wording "UCB" in the logo appearing in the color blue. The color blue appears in the four edges and the vertical line which constitute the logo. The color red appears in the wording "EPILEPSY". The color white represents a transparent area and is not a part of the mark.
Titulares e representantes
Titulares
UCB BIOPHARMA SRL
U. S. (pessoa física)
UCB PHARMA S.A.
UCB PHARMA S.A.
Representantes
Kumiko Ide Wenderoth, Lind & Ponack, L.L.P.
Classificação técnica
Classes Nice
Classe 16Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 16
Medical publications on the central nervous systemprinted reportsmanualshandbookspamphletsprospectuses and information bulletins in the field of the central nervous system
Classe 41
Education and educational training servicesproviding individual or group seminars and workshops on the prevention and treatment of disorders affecting the central nervous system
Classe 42
Scientific research; industrial design services; industrial research in the field of the central nervous system
Publicações
Histórico de despachos e eventos da marca no USPTO.
60 publicações encontradas
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/03/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/03/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/03/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/03/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/03/2022
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
04/11/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
14/08/2020
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/07/2020
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
21/05/2020
INPC
INVALIDATION PROCESSED
21/05/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
23/04/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/03/2020
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/07/2019
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
08/07/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/07/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/06/2019
ES71
TEAS SECTION 71 RECEIVED
28/06/2019
CHLD
CHANGE OF OWNER RECEIVED FROM IB
19/07/2018
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
27/03/2018
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
16/02/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
06/01/2018
RNWL
INTERNATIONAL REGISTRATION RENEWED
07/12/2017
CHLD
CHANGE OF OWNER RECEIVED FROM IB
27/08/2015
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
28/01/2015
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
28/01/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/01/2015
ES75
TEAS SECTION 71 & 15 RECEIVED
06/01/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/04/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/01/2010
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/04/2009
FIMP
FINAL DISPOSITION PROCESSED
16/04/2009
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/04/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
06/01/2009
PUBO
PUBLISHED FOR OPPOSITION
21/10/2008
NPUB
NOTICE OF PUBLICATION
01/10/2008
CNEA
EXAMINERS AMENDMENT MAILED
15/09/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
15/09/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
12/09/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/09/2008
CPRA
PRIORITY ACTION MAILED
29/07/2008
CPRA
PRIORITY ACTION WRITTEN
29/07/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/07/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/07/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
07/07/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2008
ALIE
ASSIGNED TO LIE
07/07/2008
PAPER RECEIVED
30/06/2008
RFNT
REFUSAL PROCESSED BY IB
25/01/2008
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/01/2008
RFRR
REFUSAL PROCESSED BY MPU
02/01/2008
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
31/12/2007
CNRT
NON-FINAL ACTION WRITTEN
30/12/2007
DOCK
ASSIGNED TO EXAMINER
22/12/2007
NWAP
NEW APPLICATION ENTERED
21/12/2007
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
20/12/2007
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/12/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace UCB THE EPILEPSY COMPANY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.